Apricot Capital
Venture capitalShanghai · Seed–Series A · 1 people tracked
Investment thesis
Apricot Capital invests in early-stage medical innovation, with deep expertise in pharmaceutical R&D, medical device development, and life science tools. The firm leverages its management team's backgrounds in healthcare finance, pharmaceutical research, and clinical medicine to identify and support transformative innovations in drug development, medical devices, and diagnostic tools that address unmet clinical needs.
Source: firm website, verified Aug 5, 2026.
Team · 1 people
from public directories
What they invest in
from 12 of 21 portfolio companiesBiotech ×10Healthtech ×7AI & Machine Learning ×2Advanced Manufacturing ×1Cleantech ×1Data & Infrastructure ×1Deep Tech ×1Digital Health ×1
HQs:China×7Singapore×1United States×1
Investments · 21 tracked
founders shown can be your intro pathCo-investorsDCP CapitalNextech Invest
Arnatar develops RNA therapeutics using its DARGER platform, which combines gene silencing via siRNA with protein upregulation through antisense oligonucleotides (ACT-UP1).
BiotechDeep Tech
Co-investors3E Bioventures CapitalF-Prime Capital PartnersEight Roads VenturesF-Prime CapitalGaorong VenturesLegend Star+1 more
Bellen (Beijing Liuhe Ningyuan Pharmaceutical Technology) is a contract chemistry service organization offering CRO and CDMO services for small-molecule drug synthesis, spanning drug discovery, preclinical and clinical development, and commercial-scale production.
BiotechCleantechNew MaterialsBeijing, CN
Co-investorsPuhua Capital
Geniebook is a personalised academic improvement system combining qualified teachers with technology, offering live and recorded classes, adaptive worksheets, on-demand help, and in-person tutoring targeting PSLE, O-level and A-level English, Chinese, Maths and Science.
AI & Machine LearningEdTechSaaS
Co-investorsLightspeed Venture PartnersEast Ventures
Junshi Biosciences is an innovative biopharmaceutical company that develops, manufactures, and commercializes antibody-based biologic drugs, including its PD-1 antibody toripalimab (Tuoyi/LOQTORZI) and other monoclonal antibodies for cancer and other diseases.
BiotechHealthtechShanghai, CN
MicroPort is a medical device company that develops and manufactures medical devices and technologies for the treatment of patients and use by healthcare professionals.
HealthtechMedical Devices
Co-investorsDraper Dragon
New York tablet publishing and ad-tech startup, a 2011 Techstars NY alum, acquired by Beanstock Media in August 2014.
New York City, US
Co-investorsLightbankTechstarsBetaworksEniac VenturesMorado Venture PartnersSpark Capital+2 more
PharmCube builds a full-lifecycle pharmaceutical data platform paired with AI technology, supported by a medical and pharmacology team, offering data products, media content, and consulting services to companies in the pharmaceutical industry.
AI & Machine LearningBiotechData & Infrastructure
RemeGen is a biopharmaceutical company that develops and commercializes innovative biologic drugs, including telitacicept (a dual-target BLyS/APRIL biologic for systemic lupus erythematosus) and disitamab vedotin (a HER2-targeting antibody-drug conjugate for cancers such as urothelial carcinoma).
BiotechHealthtechYantai, CN
Wang Weidong(Co-founder)Jianmin Fang(Co-founder & CEO)
Co-investorsVivo Capital
Shanghai Shengsheng is a provider of cold-chain logistics and temperature-controlled services for the biopharmaceutical and life sciences sector, covering clinical material procurement, cold-chain transport, temperature-controlled storage, and recovery/destruction for drug development, cell therapy, finished pharmaceuticals, and medical devices.
BiotechHealthtechLogistics & Supply ChainShanghai, CN
Co-investorsThe Innovation Space
TriApex is a contract research organization (CRO) providing nonclinical safety, efficacy and DMPK studies along with integrated clinical trial services from proof-of-concept to pivotal trials.
BiotechDigital HealthHealthtechNanjing, CN
Co-investorsYuanBio Venture Capital
Portfolio news
latest coverage across their companiesArnatar Therapeutics · dakota.com · Aug 18, 2026
Frequently asked questions
- What stage does Apricot Capital invest at?
- Apricot Capital invests at the Seed, Series A stages.
- What sectors does Apricot Capital focus on?
- Apricot Capital focuses on Biotech, Consumer, EdTech, Healthtech, Medical Devices, PropTech.
- Where is Apricot Capital located?
- Apricot Capital is headquartered in Shanghai, CN.
- Does Apricot Capital lead rounds?
- Apricot Capital typically participates in rounds rather than leading them.
Similar investors
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.
Norwest Venture Partners is an investment firm whose growth equity team backs private, profitable, fast-growing companies, providing capital and hands-on support through its 'invited guest' approach.
OMERS Ventures is the venture capital arm of the OMERS pension plan, investing in early-stage technology founders building solutions across North America and Europe.
K3 Ventures presents itself as an investment platform focused on collaboration and partnership between founders and stakeholders, emphasizing trust, relevance, and long-term support.
Liebenthal Ventures is the venture capital arm of a family office with roots in real estate and public-market hedge fund investing. It began investing in startups in 2013 to diversify its portfolio.